Just going by the 1:1 split and BIOAQ/LCYGF chart mirroring we all witnessed, in addition to the premature and accidental distribution a shareholder received, I’m speculating LCYBT will merge in and be taken public. I’d bet the offering price and valuation for LCY Biotechnology Holding Corp is going to be $4.16USD per share and will be listed on the NASDAQ. To me, it would make sense that any legal matters involving the securities of Bioamber Inc would have to be officially completed. That entire class action case was strategically used by the parties during the CCAA, in my opinion.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.